Clinical Trials Logo

Filter by:
NCT ID: NCT00876460 Completed - Clinical trials for Carcinoma, Non-Small-Cell Lung

BIBF 1120 + Docetaxel (Japan) in Patients With Advanced Non-small-cell Lung Cancer, Phase I

Start date: March 2009
Phase: Phase 1
Study type: Interventional

To confirm the safety of BIBF 1120 at a dose level up to 200 mg x 2/day (i.e., overseas recommended Phase III dose for combination treatment) with standard therapy of docetaxel (60 mg/m2 and 75 mg/m2) in Japanese advanced non small cell lung cancer (NSCLC) patients with stage IIIB/IV or recurrent after failure of first line chemotherapy and to determine the recommended dose for the Phase II trial.

NCT ID: NCT00876395 Completed - Breast Cancer Clinical Trials

Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer

BOLERO-1
Start date: September 10, 2009
Phase: Phase 3
Study type: Interventional

The purpose of this Phase III study was to confirm the value of adding everolimus to weekly paclitaxel and trastuzumab as treatment of HER2-overexpressing metastatic breast cancer.

NCT ID: NCT00876343 Completed - Clinical trials for Major Depressive Disorder

Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

Start date: March 2009
Phase: Phase 3
Study type: Interventional

To examine the efficacy and safety of aripiprazole versus placebo as an adjunctive therapy co-administered with either an selective serotonin reuptake inhibitor (SSRI) or a serotonin-norepinephrine reuptake inhibitor (SNRI) in patients with major depressive disorder.

NCT ID: NCT00874588 Completed - Clinical trials for Non Small Cell Lung Cancer

Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer

Start date: March 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, immune response and clinical response of different doses of HLA-A*2402 restricted epitope peptides URLC10, CDCA1, VEGFR1 and VEGFR2 emulsified with Montanide ISA 51.

NCT ID: NCT00873977 Completed - Clinical trials for Obstructive Sleep Apnea

Treatment Adherence and Outcomes in Three Modalities of Continuous Positive Airway Pressure Treatment for Obstructive Sleep Apnea

Start date: April 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the treatment adherence and effects in three modalities of Continuous Positive Airway Pressure Treatment for Obstructive Sleep Apnea.

NCT ID: NCT00873548 Completed - Clinical trials for Trochanteric Fractures

Treatment of Unstable Trochanteric Fractures With the Proximal Femoral Nail - Antirotation (PFNA)-Asia

Start date: November 2007
Phase:
Study type: Observational

The primary objective of this prospective multicenter study is to assess any fracture fixation complication and revision rates during the clinical use of the Proximal Femoral Nail Antirotation Asia (PFNA Asia) for the treatment of unstable trochanteric fractures.

NCT ID: NCT00871494 Completed - Clinical trials for Pelvic Inflammatory Disease

Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan

Start date: May 2009
Phase: Phase 3
Study type: Interventional

Azithromycin had a potent in vitro activities and broad spectrum from typical and atypical bacteria to anaerobes. Azithromycin intravenous formulation demonstrated high efficacy and eradication rate in the western clinical trials. Development of azithromycin intravenous formulation would bring the clinical benefit to patients with pelvic inflammatory disease (PID) in Japan.

NCT ID: NCT00870467 Completed - Clinical trials for Rheumatoid Arthritis

A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis

Start date: March 2009
Phase: Phase 3
Study type: Interventional

To evaluate the potential of adalimumab to inhibit radiographic progression in joint destruction compared with placebo in adult Japanese subjects with recent onset of rheumatoid arthritis.

NCT ID: NCT00869817 Recruiting - Alzheimer's Disease Clinical Trials

Dominantly Inherited Alzheimer Network (DIAN)

DIAN
Start date: January 2009
Phase:
Study type: Observational

The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.

NCT ID: NCT00868959 Completed - Bipolar Depression Clinical Trials

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Start date: April 2009
Phase: Phase 3
Study type: Interventional

This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe for the treatment of patients with bipolar I depression